Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2012 Oct 8.
Published in final edited form as: Br J Ophthalmol. 2009 Mar 19;93(6):775–781. doi: 10.1136/bjo.2008.150698

Agreement between spectral-domain and time-domain OCT for measuring RNFL thickness

G Vizzeri 1, R N Weinreb 1, A O Gonzalez-Garcia 1, C Bowd 1, F A Medeiros 1, P A Sample 1, L M Zangwill 1
PMCID: PMC3465953  NIHMSID: NIHMS153077  PMID: 19304586

Abstract

Background/aims

To evaluate spectral-domain (SD) optical coherence tomography (OCT) reproducibility and assess the agreement between SD-OCT and Time-Domain (TD) OCT retinal nerve fibre layer (RNFL) measurements.

Methods

Three Cirrus-SD-OCT scans and one Stratus-TD-OCT scan were obtained from Diagnostic Innovations in Glaucoma Study (DIGS) healthy participants and glaucoma patients on the same day. Repeatability was evaluated using Sw (within-subject standard deviation), CV (coefficient of variation) and ICC (intraclass correlation coefficient). Agreement was assessed using correlation and Bland–Altman plots.

Results

16 healthy participants (32 eyes) and 39 patients (78 eyes) were included. SD-OCT reproducibility was excellent in both groups. The CV and ICC for Average RNFL thickness were 1.5% and 0.96, respectively, in healthy eyes and 1.6% and 0.98, respectively, in patient eyes. Correlations between RNFL parameters were strong, particularly for average RNFL thickness (R2 = 0.92 in patient eyes). Bland–Altman plots showed good agreement between instruments, with better agreement for average RNFL thickness than for sectoral RNFL parameters (for example, at 90 μm average RNFL thickness, 95% limits of agreement were −13.1 to 0.9 for healthy eyes and −16.2 to −0.3 μm for patient eyes).

Conclusions

SD-OCT measurements were highly repeatable in healthy and patient eyes. Although the agreement between instruments was good, TD-OCT provided thicker RNFL measurements than SD-OCT. Measurements with these instruments should not be considered interchangeable.


Spectral domain (SD) optical coherence tomography (OCT) technology provides better scan resolution and a greater number of scans acquired at a faster rate than time domain (TD) OCT technology.1 2 These improvements have the potential to provide clinicians with enhanced tools for the diagnosis and follow-up of glaucoma. However, before a new diagnostic instrument can be introduced for use in clinical practice, good repeatability of measurements must be demonstrated in healthy and glaucomatous eyes. In addition, it is important to determine if measurements from previous generation OCT technologies are compatible with new generation technologies, both designed to identify the retinal nerve fibre layer (RNFL) and quantify its thickness.35 This study was designed to evaluate the reproducibility of SD-OCT measurements and to measure the agreement between SD-OCT and TD-OCT RNFL measurements in healthy and patient eyes.

MATERIALS AND METHODS

For this prospective longitudinal study, participants were enrolled from the UCSD Diagnostic Innovations in Glaucoma Study (DIGS), an ongoing study designed to evaluate optic nerve structure and visual function in glaucoma. Informed consent was obtained from each participant, and the University of California San Diego Institutional Review Board approved all methodology. Study methods adhered to the provisions of the Declaration of Helsinki guidelines for research involving human participants.

To be included in the study, the eyes of all participants required good-quality stereo-photography (TRC-SS, Topcon Instruments, Paramus, New Jersey) of the optic disc and reliable (false positives, fixation losses and false negatives ≤25% with no observable testing artefacts) standard automated perimetry (SAP, Humphrey Field Analyzer II with Swedish Interactive Thresholding Algorithm, Carl Zeiss Meditec, Dublin, California) testing within 6 months of testing using Stratus TD-OCT and Cirrus SD-OCT protocols (see below).

In addition to the testing described above, each study participant underwent a comprehensive ophthalmological evaluation including a review of medical history, best-corrected visual acuity testing, slit-lamp biomicroscopy, intraocular pressure (IOP) measurement with Goldmann applanation tonometry, gonioscopy and dilated slit-lamp fundus examination with a 78 D lens. To be included in the study, participants had to have a best-corrected acuity better than or equal to 20/40, spherical refraction within ±5.0 D and cylinder correction within ±3.0 D, and open angles on gonioscopy. Eyes with coexisting retinal disease, uveitis or non-glaucomatous optic neuropathy were excluded.

Because this study was designed to evaluate measurement repeatability in a typical clinical patient population to which the instrument should apply, study participants were classified as either healthy controls or patients with glaucomatous or suspicious appearing optic discs by stereo-photography and/or repeatable abnormal SAP results and/or history of elevated IOP in at least one eye prior to study entry. Each stereophotograph was graded as glaucomatous or normal by two experienced observers based on the presence or absence of neuroretinal rim thinning, RNFL thinning (focal or diffuse), or excavation and/or undermining of the cup characteristic of glaucoma. In cases of disagreement between observers, a third observer adjudicated the decision. Abnormal SAP results required pattern standard deviation (PSD) with p≤5% and/or Glaucoma Hemifield Test outside normal limits by STATPAC analysis on two consecutive tests. History of elevated IOP was defined as two or more measurements ≥23 mm Hg using Goldmann applanation tonometry. Healthy controls were normal in both eyes for the above tests.

INSTRUMENTATION

The Cirrus SD-OCT and the Stratus TD-OCT are non-invasive imaging devices that obtain cross-sectional images of ocular microstructures.6

Cirrus SD-OCT (software version 3.0; Carl Zeiss Meditec, Dublin, California) utilises spectral domain optical coherence tomography technology to acquire OCT data with better resolution (5 μm compared with approximately 10 μm axial resolution in tissue) about 70 times faster (27 000 vs 400 A-scans/s) than time-domain OCT technology.1 For the Cirrus SD-OCT, the Optic Disk Cube 200×200 protocol was used for acquisition and analysis. This protocol generates a cube of data through a 6 mm square grid by acquiring a series of 200 horizontal scan lines each composed of 200 A-scans. For analysis, Cirrus algorithms identify the centre of the optic disc and automatically place a calculation circle of 3.46 mm diameter around it. The anterior and posterior margins of the RNFL are delineated, and after extracting from the data cube 256 A-scan samples along the path of the calculation circle, the system calculates the RNFL thickness at each point on the circle. To investigate the repeatability of RNFL thickness measurements, three consecutive Optic Disk Cube scans were acquired and analysed for each eye.

For the Stratus TD-OCT, the Fast RNFL thickness acquisition protocol (software version 4.0.7; Carl Zeiss Meditec) was used. Three scans were automatically acquired consecutively using a circle with a standardised diameter of 3.4 mm. An automated computer algorithm delineates the anterior and posterior margins of the RNFL.7

Both the Cirrus SD-OCT and the Stratus TD-OCT provide average RNFL thickness measurements overall and by quadrants and clock hours on a similar printout (see fig 1 for a healthy eye and a glaucomatous eye (patient)). For the purpose of this study, average RNFL thickness and quadrant and clock hour thicknesses were exported from the Stratus TD-OCT and the Cirrus SD-OCT.

Figure 1.

Figure 1

Examples showing the similarities between Cirrus spectral domain (SD) optical coherence tomography (OCT) and time-domain OCT printouts in one eye of a healthy participant and a patient. RNFL, retinal nerve fibre layer.

All measurements in this study were performed on the same day within a 2 h time period with Stratus TD-OCT taken first, without pupil dilation and by the same operator (technician), experienced with taking OCT images and with centring the scans on the optic disc using currently suggested techniques for the Stratus TD-OCT (ie, with the help of a landmark feature).8 Internal fixation was used for all scans. For both instruments, scans with signal strength <6 were excluded, as per manufacturers' instructions. In addition, criteria for determining scan quality as reported in previous studies were followed:7 the optic disc and scan circle were visible on the fundus image, colour saturation was even and dense throughout the entire scan with red colour visible in the retinal pigment epithelium, and RNFL was visible with no missing or blank areas within the scan pattern.

STATISTICAL ANALYSIS

Cirrus SD-OCT repeatability was assessed using the within-subject standard deviation (Sw), coefficient of variation (CV) and intraclass correlation coefficient (ICC). Because the Stratus TD-OCT Fast RNFL acquisition protocol consists of three single circle scans acquired consecutively and subsequently averaged, the average of the measurements taken from the three Cirrus SD-OCT scans was used for comparison with the Stratus TD-OCT measurements. Agreement between Cirrus SD-OCT and Stratus TD-OCT measurements was evaluated using correlations (R2) and Bland–Altman plots. The method of generalised estimating equations (GEE) was applied to adjust for the correlation between the two eyes of each subject.9

For the Bland–Altman plots, the reported 95% limits of agreement were calculated based on a regression approach for non-uniform differences.10

In addition, because the standard deviations of the measurements from the two devices differed, modified Bland–Altman plots for the average RNFL thickness were displayed by plotting the difference versus the weighted average of the two measurements.11

Analyses were performed using JMP version 6.1 software (SAS Institute, Cary, North Carolina) and SPSS version 15.0 software. A p value less than 0.05 was considered statistically significant.

RESULTS

All available DIGS participants who consented to the study and were imaged with SD-OCT and TD-OCT were selected for the analysis. Sixteen healthy participants (32 eyes) and 39 patients (78 eyes) were included. All subjects had at least three good-quality scans from SD-OCT and one from TD-OCT. Four eyes of two patients were excluded for signal strength <6 (two eyes using SD-OCT, four eyes using TD-OCT). Demographic and ocular characteristics of healthy and patient eyes/participants are shown in table 1.

Table 1.

Demographic data from 110 eyes of 55 individuals included in the analysis

Healthy participants (n = 16, 32 eyes) Patients (n = 39, 78 eyes) p(t)
Female (%) 10 (62.5) 21 (53.8) 0.49 (χ2)
Mean age (years) (SD) 65.4 (9.56) 66.9 (10.2) 0.41
Mean deviation (dB) (SD) 0.07 (0.75) −1.87 (2.8) <0.001
Pattern standard deviation (dB) (SD) 1.52 (0.22) 3.71 (3.23) <0.001
Intraocular pressure (mm Hg) (SD) 15.1 (2.16) 15.9 (5.32) 0.56
Disc area (mm2)* (SD) 1.64 (0.36) 1.91 (0.51) <0.05
*

Measured using the Heidelberg Retina Tomograph (Heidelberg Engineering, Heidelberg, Germany).

Statistically significant differences in SAP MD and SAP PSD at the time of testing were observed between study groups. Table 2 shows the mean RNFL thickness, Sw, CV and ICC for average RNFL, quadrant and clock hour thicknesses calculated from the three Optic Disk Cube 200×200 scans in the two groups.

Table 2.

Spectral-domain (SD) optical coherence tomography retinal nerve fibre layer (RNFL) thickness reproducibility in healthy participants and patients

Healthy participants
Patients
Mean RNFL thickness (μm) (95% Cl) Sw (1.96 SE) CV% ICC (95% Cl) Mean RNFL thickness (μm) (95% Cl) Sw (1.96 SE) CV% ICC (95% Cl)
Temporal 65.8 (60.7 to 70.9) 1.5 (0.33) 2.3 0.98 (0.97 to 0.99) 58.3 (55.8 to 60.8) 1.6 (0.51) 2.7 0.94 (0.91 to 0.96)
Superior 110.9 (106.1 to 115.6) 2.8 (0.71) 2.6 0.93 (0.89 to 0.96) 93.1 (89.1 to 97) 2.2 (0.33) 2.5 0.98 (0.97 to 0.99)
Nasal 70.2 (66.2 to 74.3) 2.9 (0.79) 4.4 0.90 (0.83 to 0.94) 66.1 (63.8 to 68.4) 2.4 (0.4) 3.7 0.92 (0.89 to 0.95)
Inferior 112.4 (107 to 117.7) 2.6 (0.69) 2.3 0.95 (0.92 to 0.98) 96.4 (91.8 to 101.1) 2.8 (0.58) 3.1 0.97 (0.95 to 0.98)
Average 89.8 (86.6 to 93) 1.3 (0.38) 1.5 0.96 (0.94 to 0.98) 78.4 (76 to 81) 1.2 (0.19) 1.6 0.98 (0.97 to 0.99)
1-o'clock 98.8 (93 to 104.6) 4.9 (1.97) 5 0.81 (0.69 to 0.89) 84.1 (80.2 to 88.1) 3.6 (0.51) 4.3 0.94 (0.92 to 0.96)
2-o'clock 82.7 (75.9 to 89.4) 5 (1.57) 6.6 0.88 (0.80 to 0.94) 78.6 (74.6 to 82.6) 3.5 (0.6) 4.8 0.94 (0.92 to 0.96)
3-o'clock 61.2 (57.6 to 64.8) 2.4 (0.76) 4.2 0.90 (0.83 to 0.94) 59.4 (57 to 61.9) 3 (0.49) 5.1 0.89 (0.85 to 0.93)
4-o'clock 66.8 (61.6 to 72) 3.3 (0.61) 4.9 0.94 (0.89 to 0.97) 60.2 (57.8 to 62.6) 3 (0.52) 5 0.88 (0.83 to 0.92)
5-o'clock 92.4 (83.8 to 100.9) 4 (0.81) 4.1 0.97 (0.94 to 0.98) 82.4 (78.5 to 86.3) 3.9 (0.73) 4.9 0.92 (0.88 to 0.94)
6-o'clock 121.5 (114.8 to 128.2) 4.3 (1.34) 3.5 0.91 (0.84 to 0.95) 103.3 (97.4 to 109) 4.9 (1.06) 5.2 0.94 (0.91 to 0.96)
7-o'clock 123.2 (112.2 to 134.3) 4.4 (0.94) 3.6 0.97 (0.95 to 0.99) 103.5 (96 to 111.1) 4.1 (0.85) 4.5 0.97 (0.96 to 0.98)
8-o'clock 70.3 (62.4 to 78.3) 2.7 (0.78) 3.6 0.97 (0.95 to 0.99) 58.1 (55.3 to 60.9) 2.4 (0.65) 4 0.91 (0.88 to 0.94)
9-o'clock 50.6 (47.3 to 54) 1.1 (0.24) 2.3 0.98 (0.96 to 0.99) 48.1 (45.6 to 50.5) 1.6 (0.94) 2.9 0.84 (0.78 to 0.89)
10-o'clock 76.4 (70.1 to 82.6) 2.3 (0.76) 3.1 0.97 (0.94 to 0.98) 68.6 (64.9 to 72.3) 2.2 (0.47) 3.3 0.97 (0.95 to 0.98)
11-o'clock 120.6 (111.8 to 129.4) 4.3 (0.85) 3.7 0.96 (0.93 to 0.98) 104.2 (99 to 109.4) 4.4 (0.78) 4.6 0.94 (0.92 to 0.96)
12-o'clock 113.2 (105.6 to 120.8) 4.4 (1.01) 3.9 0.94 (0.90 to 0.97) 90.7 (84.8 to 96.6) 4.1 (0.86) 5 0.95 (0.93 to 0.97)

CV, coefficient of variation; ICC, intraclass correlation coefficient; Sw, within-subjects SD.

In general, the reproducibility was excellent in both groups, especially for average RNFL thickness, with quadrants performing better than clock hours. The nasal quadrant provided a higher Sw and CV and lower ICC, suggesting that measurements were less repeatable for this sector (and corresponding clock hours) than for other sectors. For example, in patients, Sws were 2.4 and 2.2, CVs were 3.7 and 2.5, and ICCs were 0.92 and 0.98 for the nasal and superior quadrants, respectively.

Table 3 shows the 95% limits of agreement and R2 values for quadrants and average RNFL thickness in the two groups.

Table 3.

Mean with 95% limits of agreement* (mean values shown are spectral-domain optical coherence tomography (SD-OCT) minus time-domain optical coherence tomography (TD-OCT)) and correlation (R2) between SD-OCT and TD-OCT measurements in healthy participants and patients

Healthy participants
Patients
Mean (μm) (95% limits of agreement) R2 Mean (μm) (95% limits of agreement) R2
TEMP RNFL −6.3 (3.4 to 0.14×Temp RNFL thickness ± 18.0) 0.76* −7.8 (3.3 to 0.18×Temp RNFL thickness ± 10.0) 0.85*
SUP RNFL −9.6 (3.4 to 0.11×Sup RNFL thickness ± 24.9) 0.47* −8.7 (14.6 to 0.24×Sup RNFL thickness ± 18.4) 0.75*
NAS RNFL −7 (20.1 to 0.36×Nas RNFL thickness ± 20.0) 0.55* −1.5 (34 to 0.52×Nas RNFL thickness ± 17.4) 0.54*
INF RNFL −9 (9.2 to 0.15×Inf RNFL thickness ± 20.4) 0.69* −4.5 (4.5 to 0.09×Inf RNFL thickness ± 14.5) 0.86*
AVG RNFL −8 (11.0 to 0.19×Avg RNFL thickness ± 7.0) 0.87* −5.7 (12.4 to 0.23×Avg RNFL thickness ± 7.9) 0.92*
*

95% limits of agreement are expresses as bo+ b1×value of retinal nerve fibre layer (RNFL) thickness ±1.96SDresiduals.

AVG RNFL, average RNFL thickness; INF RNFL, inferior quadrant RNFL thickness; NAS RNFL, nasal quadrant RNFL thickness; RNFL, retinal nerve fibre layer; SUP RNFL, superior quadrant RNFL thickness; TEMP RNFL, temporal quadrant RNFL thickness.

Figure 2 describes the correlation between average RNFL thickness measurements from SD-OCT and TD-OCT in one randomly selected eye (ie, left or right) of healthy participants and patients. In general, all RNFL thickness measurements were highly correlated in both groups, with the association being particularly strong for the average RNFL thickness (R2 was 0.87 and 0.92 in healthy participants and patients, respectively).

Figure 2.

Figure 2

Scatter plot showing the correlation between spectral-domain optical coherence tomography (SD-OCT) and time-domain optical coherence tomography (TD-OCT) average retinal nerve fibre layer (RNFL) thickness in one randomly selected eye of healthy participants and patients.

The mean of the differences between SD-OCT and TD-OCT and 95% limits of agreement in table 3 show that TD-OCT consistently provided thicker RNFL measurements than SD-OCT for both global and sectoral parameters. Based on the 95% limits of agreement reported in table 3 for the parameter average RNFL thickness, if an arbitrary value of 90 μm is assumed (ie, “Avg RNFL thickness” in the formula is replaced with 90 μm), the calculated 95% limits of agreement are −13.1 to 0.9 and −16.2 to −0.3 μm in healthy and patient eyes, respectively.

Figure 3 shows the modified Bland–Altman plots for the agreement between SD-OCT and TD-OCT for the average RNFL thickness in healthy participants and patients. Based on the data available from this study, the coefficient used to obtain the weighted average for SD-OCT and TD-OCT was 0.86. The modified Bland–Altman plots show that TD-OCT provides thicker RNFL measurements than SD-OCT, particularly in eyes with thick RNFL measurements demonstrated by calculating the slopes of the average RNFL plots in fig 3 (r = −0.36; p<0.05 and r = –0.48; p<0.05 in healthy participants and patients, respectively). A similar effect was observed in the Bland–Altman plots for the four quadrants (data not shown).

Figure 3.

Figure 3

Modified Bland–Altman plots for agreement between spectral-domain optical coherence tomography (SD-OCT) and time-domain optical coherence tomography (TD-OCT) average retinal nerve fibre layer thickness in healthy participants (A) and patients (B). To obtain the modified Bland–Altman plots, the difference was plotted against the weighted average of SD-OCT and TD-OCT measurements. The regression line is shown along with the 95% limits of agreement in dotted lines displayed as a function of the weighted average.

DISCUSSION

Assessing an instrument's repeatability is an important first step in the evaluation of a new technology for use in clinical practice. Current results suggest that SD-OCT RNFL thickness measurements are highly repeatable and that reproducibility is excellent in both healthy participants and patients. In addition, strong correlations and a good agreement were found between RNFL thickness measurements performed using the SD-OCT and the TD-OCT, suggesting that the two instruments may provide similar estimates of RNFL thickness. This information is important because TD-OCT has already demonstrated the ability to detect glaucomatous structural damage.1219 These results show that this technology is promising for measuring RNFL thickness in healthy and glaucomatous eyes.

Several earlier studies have shown that TD-OCT measurements are reproducible, with RNFL thickness in glaucomatous eyes being slightly more variable than in normal eyes.8 2022 However, results from the current study showed that SD-OCT measurements were similarly repeatable in both healthy and patient eyes. This is despite the fact that differences in disc area between healthy and patient eyes favoured a lower repeatability in patient eyes (due to measurements obtained closer to the disc margin in patient eyes that had larger optic discs on average).22 It is possible that SD-OCT provides more robust algorithms than TD-OCT for RNFL delineation, producing less variability in diseased eyes. Alternately, results may be due to differences in the study populations and the criteria applied for classifying healthy and glaucoma. In this study, most of the glaucomatous eyes had early to moderate disease based on the Glaucoma Staging System (GSS) classification for visual-field abnormalities;23 of the 78 patient's eyes, 24 (30.8%) were classified as GSS Stage 0, 35 (44.9%) were classified as Stage 1, 17 (21.8%) were classified as Stage 2, and two (2.5%) were classified as Stage 3. It is possible that repeatability may be worse in eyes with more advanced glaucoma.

One of the advantages of the Cirrus SD-OCT is that it does not require manual centring of the scan on the optic disc as long as the peripapillary region is included in the Optic Disk Cube 200×200 scan. The scan registration process performed by the Cirrus algorithms is fully automated, reducing the likelihood of operator error. Previous studies with TD-OCT have shown that misalignment of the circle scan by the operator can significantly affect RNFL measurements, particularly in quadrants and clock hours.24 However, in the absence of an eye-tracking system, Cirrus SD-OCT scan acquisition might still be affected by eye movements. In this study, Cirrus Optic Disk Cube 200×200 maps were checked for the presence of eye-movement artefacts such as vessel misalignment and/or image distortion. Nevertheless, as previously found using the TD-OCT, the nasal quadrant RNFL thickness was the most variable sector. As previously suggested for TD-OCT, it is possible that the angle of incidence of the illuminating beam is such that the RNFL is dimmer nasally, thus limiting the ability of the detection algorithm to consistently identify the RNFL at the same location over time.21 25

Our results showed that SD-OCT and TD-OCT thickness measurements are highly correlated. As expected, the correlation was particularly strong for average RNFL thickness compared with quadrant thickness. These results were confirmed in multivariate analysis using GEE adjusting for the correlation between two eyes of the same subject (data not shown). Although a good agreement was found for all parameters, Bland–Altman plots showed that TD-OCT RNFL measurements were consistently thicker than SD-OCT measurements, particularly in eyes with thick RNFL measurements. The reason for this finding is unclear. Because signal strength has been shown to affect RNFL thickness measurements using TD-OCT,2631 it is possible that differences in signal strength between the two instruments may be one of the causes. However, in this study, only scans with adequate signal strength were included, and no differences in signal strength were observed between scans taken using the two devices (average signal strengths for SD-OCT and TD-OCT were 8.4 (1.9) and 8.7 (1.1), respectively; t test, p = 0.73). Nevertheless, in healthy participants, the average RNFL thickness measured with SD-OCT was not associated with signal strength (R2 = 0.02, p = 0.11), while TD-OCT RNFL thickness showed a positive, although weak association with signal strength (ie, the greater the signal strength, the greater the thickness, R2 = 0.11, p<0.05). Alternatively, the discrepancy in the measurements could be related to an intrinsic difference between the instruments and software edge-detection algorithms for measuring the RNFL, and the precise location of the RNFL measured. It is likely that SD-OCT, by providing scans at a higher resolution than TD-OCT, may also provide measurements that reflect a more accurate delineation of the RNFL margins. Future studies might clarify which instrument offers greater accuracy in estimating the “true” in vivo RNFL thickness.

This study evaluated the reproducibility of RNFL thickness measurements using the commercially available Cirrus SD-OCT in healthy eyes and glaucoma patient eyes. A previous report on SD-OCT measurement variability was obtained using a prototype device on a limited sample of healthy eyes.32

In conclusion, this study showed that SD-OCT provides excellent reproducibility suggesting that this technology is promising for detecting small structural changes over time in most eyes. As RNFL measurements with TD-OCT are thicker than with SD-OCT, measurements with these instruments should not be considered interchangeable. Further studies with longer follow-up are needed in order to assess intervisit variability and to better evaluate variance components that could affect measurements repeatability.

Acknowledgments

Funding: NIH EY011008, NIH EY008208 and participant incentive grants in the form of glaucoma medication at no cost from Alcon Laboratories, Allergan, Pfizer and SANTEN.

Footnotes

Competing interests: Carl Zeiss Meditec: FAM (F, R), PAS (F), RNW (F,C), LMZ (F). Haag-Streit: PAS (F). Heidelberg Engineering: FAM (F), RNW (F), LMZ (F). Lace Elettronica: CB (F). Optovue: LMZ (F). Pfizer: CB (F). Reichert Instruments: FAM (R). Welch-Allyn: PAS (F).

Ethics approval: Ethics approval was provided by University of California San Diego Institutional Review Board.

Patient consent: Obtained.

REFERENCES

  • 1.van Velthoven ME, Faber DJ, Verbraak FD, et al. Recent developments in optical coherence tomography for imaging the retina. Progr Retin Eye Res. 2007;26:57–77. doi: 10.1016/j.preteyeres.2006.10.002. [DOI] [PubMed] [Google Scholar]
  • 2.Chen TC, Cense B, Pierce MC, et al. Spectral domain optical coherence tomography: ultra-high speed, ultra-high resolution ophthalmic imaging. Arch Ophthalmol. 2005;123:1715–20. doi: 10.1001/archopht.123.12.1715. [DOI] [PubMed] [Google Scholar]
  • 3.Wojtkowski M, Leitgeb R, Kowalczyk A, et al. In vivo human retinal imaging by Fourier domain optical coherence tomography. J Biom Opt. 2002;7:457–63. doi: 10.1117/1.1482379. [DOI] [PubMed] [Google Scholar]
  • 4.Nassif N, Cense B, Hyle Park B, et al. In vivo human retinal imaging by ultrahigh-speed spectral domain optical coherence tomography. Opt Lett. 2004;29:480–2. doi: 10.1364/ol.29.000480. [DOI] [PubMed] [Google Scholar]
  • 5.de Boer JF, Cense B, Hyle Park B, et al. Improved signal-to-noise ratio in spectral-domain compared with time-domain optical coherence tomography. Opt Lett. 2003;28:2067–9. doi: 10.1364/ol.28.002067. [DOI] [PubMed] [Google Scholar]
  • 6.Huang D, Swanson EA, Lin CP, et al. Optical coherence tomography. Science. 1991;254:1178–81. doi: 10.1126/science.1957169. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Budenz DL, Chang RT, Huang X, et al. Reproducibility of retinal nerve fiber thickness measurements using the Stratus OCT in normal and glaucomatous eyes. Invest Ophthalmol Vis Sci. 2005;46:2440–3. doi: 10.1167/iovs.04-1174. [DOI] [PubMed] [Google Scholar]
  • 8.Vizzeri G, Bowd C, Medeiros FA, et al. Scan tracking coordinates for improved centering of Stratus OCT scan pattern. J Glaucoma. 2009;18:81–7. doi: 10.1097/IJG.0b013e31816b3063. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Hanley JA, Negassa A, Edwardes MD, et al. Statistical analysis of correlated data using Generalized Estimating Equations: an orientation. Am J Epidemiol. 2003;157:364–75. doi: 10.1093/aje/kwf215. [DOI] [PubMed] [Google Scholar]
  • 10.Bland JM, Altman DG. Measuring agreement in method comparison studies. Stat Meth Med Res. 1999;8:135–60. doi: 10.1177/096228029900800204. [DOI] [PubMed] [Google Scholar]
  • 11.Proschan MA, Leifer ES. Comparison of two or more measurement techniques to a standard. Contemp Clin Trials. 2006;27:472–82. doi: 10.1016/j.cct.2006.02.008. [DOI] [PubMed] [Google Scholar]
  • 12.Bagga H, Greenfield DS. Quantitative assessment of structural damage in eyes with localized visual field abnormalities. Am J Ophthalmol. 2004;137:797–805. doi: 10.1016/j.ajo.2003.11.060. [DOI] [PubMed] [Google Scholar]
  • 13.Budenz DL, Michael A, Chang RT, et al. Sensitivity and specificity of the StratusOCT for perimetric glaucoma. Ophthalmology. 2005;112:3–9. doi: 10.1016/j.ophtha.2004.06.039. [DOI] [PubMed] [Google Scholar]
  • 14.Medeiros FA, Zangwill LM, Bowd C, et al. Evaluation of retinal nerve fiber layer, optic nerve head, and macular thickness measurements for glaucoma detection using optical coherence tomography. Am J Ophthalmol. 2005;139:44–55. doi: 10.1016/j.ajo.2004.08.069. [DOI] [PubMed] [Google Scholar]
  • 15.Brusini P, Salvetat ML, Zeppieri M, et al. Comparison between GDx VCC scanning laser polarimetry and Stratus OCT optical coherence tomography in the diagnosis of chronic glaucoma. Acta Ophthalmol Scand. 2006;84:650–5. doi: 10.1111/j.1600-0420.2006.00747.x. [DOI] [PubMed] [Google Scholar]
  • 16.Sihota R, Sony P, Gupta V, et al. Diagnostic capability of optical coherence tomography in evaluating the degree of glaucomatous retinal nerve fiber damage. Invest Ophthalmol Vis Sci. 2006;47:2006–10. doi: 10.1167/iovs.05-1102. [DOI] [PubMed] [Google Scholar]
  • 17.Cheng HY, Huang ML. Discrimination between normal and glaucomatous eyes using Stratus optical coherence tomography in Taiwan Chinese subjects. Graefes Arch Clin Exp Ophthalmol. 2005;243:894–902. doi: 10.1007/s00417-005-1140-y. [DOI] [PubMed] [Google Scholar]
  • 18.Medeiros FA, Zangwill LM, Bowd C, et al. Comparison of the GDx VCC scanning laser polarimeter, HRT II confocal scanning laser ophthalmoscope, and Stratus OCT optical coherence tomograph for the detection of glaucoma. Arch Ophthalmol. 2004;122:827–37. doi: 10.1001/archopht.122.6.827. [DOI] [PubMed] [Google Scholar]
  • 19.Jeoung JW, Park KH, Kim TW, et al. Diagnostic ability of optical coherence tomography with a normative database to detect localized retinal nerve fiber layer defects. Ophthalmology. 2005;112:2157–63. doi: 10.1016/j.ophtha.2005.07.012. [DOI] [PubMed] [Google Scholar]
  • 20.Paunescu LA, Schuman JS, Price LL, et al. Reproducibility of nerve fiber layer thickness, macular thickness, and optic nerve head measurements using StratusOCT. Invest Ophthalmol Vis Sci. 2004;45:1716–24. doi: 10.1167/iovs.03-0514. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Budenz DL, Fredette MJ, Feuer WJ, et al. Reproducibility of peripapillary retinal nerve fiber thickness measurements with Stratus OCT in glaucomatous eyes. Ophthalmology. 2008;115:661–6. doi: 10.1016/j.ophtha.2007.05.035. [DOI] [PubMed] [Google Scholar]
  • 22.Schuman JS, Pedut-Kloizman T, Hertzmark E, et al. Reproducibility of nerve fiber layer thickness measurements using optical coherence tomography. Ophthalmology. 1996;103:1889–98. doi: 10.1016/s0161-6420(96)30410-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Mills RP, Budenz DL, Lee PP, et al. Categorizing the stage of glaucoma from pre-diagnosis to end-stage disease. Am J Ophthalmol. 2006;141:24–30. doi: 10.1016/j.ajo.2005.07.044. [DOI] [PubMed] [Google Scholar]
  • 24.Vizzeri G, Bowd C, Medeiros FA, et al. Effect of improper scan alignment on retinal nerve fiber layer thickness measurements using Stratus optical coherence tomograph. J Glaucoma. 2008;17:341–9. doi: 10.1097/IJG.0b013e31815c3aeb. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Knighton RW, Qian C. An optical model of the human retinal nerve fiber layer: implications of directional reflectance for variability of clinical measurements. J Glaucoma. 2000;9:56–62. doi: 10.1097/00061198-200002000-00011. [DOI] [PubMed] [Google Scholar]
  • 26.Wu Z, Vazeen M, Varma R, et al. Factors associated with variability in retinal nerve fiber layer thickness measurements obtained by optical coherence tomography. Ophthalmology. 2007;114:1505–12. doi: 10.1016/j.ophtha.2006.10.061. [DOI] [PubMed] [Google Scholar]
  • 27.Cheung CY, Leung CK, Lin D, et al. Relationship between retinal nerve fiber layer measurement and signal strength in optical coherence tomography. Ophthalmology. 2008;115:1347–51. doi: 10.1016/j.ophtha.2007.11.027. [DOI] [PubMed] [Google Scholar]
  • 28.van Velthoven ME, van der Linden MH, de Smet MD, et al. Influence of cataract on optical coherence tomography image quality and retinal thickness. Br J Ophthalmol. 2006;90:1259–62. doi: 10.1136/bjo.2004.097022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Stein DM, Wollstein G, Ishikawa H, et al. Effect of corneal drying on optical coherence tomography. Ophthalmology. 2006;113:985–91. doi: 10.1016/j.ophtha.2006.02.018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Barkana Y, Bugansky-Eliash Z, Gerber Y, et al. Inter-device variability of the Stratus optical coherence tomography. Am J Ophthalmol. 2009;147:260–6. doi: 10.1016/j.ajo.2008.08.008. [DOI] [PubMed] [Google Scholar]
  • 31.Kok PH, van Dijk HW, van den Berg TJ, et al. A model for the effect of disturbances in the optical media on the OCT image quality. Invest Ophthalmol Vis Sci. 2009;50:787–92. doi: 10.1167/iovs.08-2364. [DOI] [PubMed] [Google Scholar]
  • 32.Gabriele ML, Ishikawa H, Wollstein G, et al. Peripapillary nerve fiber layer thickness profile determined with high speed, ultrahigh resolution optical coherence tomography high-density scanning. Invest Ophthalmol Vis Sci. 2007;48:3154–60. doi: 10.1167/iovs.06-1416. [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES